Atlas Trials

Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients

Clinical trial NCT04018261 · COMPLETED

Trial details

NCT number
NCT04018261
Sponsor
Banc de Sang i Teixits
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CMV ViremiaImmunosuppression-related Infectious Disease
Start date
2019-07-04
Primary completion
2021-10-18
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.